FDA Notices of Judgment Collection, 1908-1966

Search

Start Over Titles 461. Adulteration and misbranding of ampuls of ephedrine sulfate, quinine dihydrochloride, and pituitary solution. U. S. v. American Parentrasol Laboratories, Inc., and George Blank. Corporation lined $400; George Blank fined $400. ✖Remove constraint Titles: 461. Adulteration and misbranding of ampuls of ephedrine sulfate, quinine dihydrochloride, and pituitary solution. U. S. v. American Parentrasol Laboratories, Inc., and George Blank. Corporation lined $400; George Blank fined $400.

Refine by:

  • 461. Adulteration and misbranding of ampuls of ephedrine sulfate, quinine dihydrochloride, and pituitary solution. U. S. v. American Parentrasol Laboratories, Inc., and George Blank. Corporation lined $400; George Blank fined $400.1